急性侵袭性真菌性鼻窦炎患者基于临床严重度分期系统的生存预后因素
这项回顾性队列研究纳入1992年6月1日至2022年12月31日在华盛顿大学医学中心及Barnes-Jewish医院经病理确诊的71例成人急性侵袭性真菌性鼻窦炎(AIFS)患者,采用序贯隔离与联合整合方法构建预测6个月总生存的综合分期系统。症状、合并症负担及严重中性粒细胞减少的存在与持续时间与6个月生存相关,据此形成3类临床严重度分期系统,A、B、C期6个月生存率分别为75%、41%、18%。综合分期系统的区分能力为中等(C统计量0.63)。
要点
- 症状、合并症负担及严重中性粒细胞减少的存在与持续时间与AIFS患者6个月生存相关。
- 3类临床严重度分期系统6个月生存率:A期75%(n=16)、B期41%(n=27)、C期18%(n=28)。
- 综合分期系统区分能力为中等(C统计量0.63)。
核心结论
- 该队列研究支持AIFS就诊时症状学、合并症负担及持续性严重中性粒细胞减少的临床重要性。
- 综合临床分期系统可能有助于临床医生对AIFS患者进行咨询及开展临床研究。
研究设计与样本
- 回顾性队列研究,纳入1992年6月1日至2022年12月31日在华盛顿大学医学中心及Barnes-Jewish医院(密苏里州圣路易斯市一家三级医疗中心)经病理确诊的成人AIFS患者。
- 共纳入71例经病理确诊的AIFS患者,队列中位(范围)年龄为56(19-63)岁,男性47例(66%)。
- 中位(范围)随访时间为2(0-251)个月。
- 采用序贯隔离与联合整合方法构建预测6个月总生存的综合分期系统。
- 数据分析时间为2023年4月至7月。
主要发现
- 71例患者中6个月内存活28例,生存率为39%。
- 症状、合并症负担及严重中性粒细胞减少的存在与持续时间与6个月生存相关,并被整合为3类临床严重度分期系统。
- 3类临床严重度分期系统6个月生存率:A期75%(n=16)、B期41%(n=27)、C期18%(n=28)。
- 综合分期系统的区分能力为中等(C统计量0.63)。
关键数值与推荐
- 临床严重度分期系统分为3类:A期(n=16)6个月生存率75%,B期(n=27)6个月生存率41%,C期(n=28)6个月生存率18%。
- 综合分期系统区分能力为中等(C统计量0.63)。
临床怎么用
- 作者认为综合临床分期系统可能有助于临床医生对AIFS患者进行咨询及开展临床研究。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Despite the aggressive progression of fulminant acute invasive fungal sinusitis (AIFS), data on prognostic factors have been disparate, hindering the development of a staging system. A composite staging system may improve prognostication for patient counseling and conduct of clinical research. OBJECTIVE: To identify prognostically important factors in AIFS and to incorporate the factors into a comprehensive Functional Severity Staging System and Clinical Severity Staging System. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study included adult patients diagnosed with pathology-proven AIFS from June 1, 1992, to December 31, 2022, at Washington University Medical Center and Barnes-Jewish Hospital, a tertiary care center in St Louis, Missouri. Data were analyzed from April to July 2023. MAIN OUTCOME AND MEASURES: Sequential sequestration and conjunctive consolidation was used to develop a composite staging system to predict 6-month overall survival. RESULTS: Of 71 patients with pathology-proven AIFS over the 30-year period, the median (range) age of the cohort was 56 (19-63) years, and there were 47 (66%) male patients. The median (range) follow-up time was 2 (0-251) months. There were 28 patients alive within 6 months, for a 39% survival rate. Symptoms, comorbidity burden, and presence and duration of severe neutropenia were associated with 6-month survival and were consolidated into a 3-category Clinical Severity Staging System with 6-month survival of 75% for stage A (n = 16), 41% for stage B (n = 27), and 18% for stage C (n = 28). The discriminative power of the composite staging system was moderate (C statistic, 0.63). CONCLUSION AND RELEVANCE: This cohort study supports the clinical importance of symptomatology, comorbidity burden, and prolonged severe neutropenia at the time of AIFS presentation. The composite clinical staging system may be useful for clinicians when counseling patients with AIFS and conducting clinical research.
引用
- Munyemana MA, Kallogjeri D, Chernock R, et al. Prognostic Factors for Survival Using a Clinical Severity Staging System Among Patients With Acute Invasive Fungal Sinusitis. JAMA Otolaryngol Head Neck Surg. 2024. PMID: 38421674. doi:10.1001/jamaoto.2024.0042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。